The Latest
-
Deep Dive
4 questions about the FDA’s approach to generative AI
The medtech industry is awaiting FDA guidance on generative AI. The agency has sought feedback in advisory meetings and a discussion paper as the technology becomes more prevalent.
-
Zimmer restructures Americas leadership team
The company promoted three executives and eliminated a fourth position as part of changes intended to support its ongoing commercial transformation.
-
Labcorp acquires MLM Medical Labs in global expansion
Buying MLM gives Labcorp a wholly owned laboratory network that spans North America, Europe, Asia and Africa.
-
5 takeaways from Oura’s IPO filing
The wearables firm’s sales are growing, and it is adding more paid members, but questions loom about whether the company will need to approach future features as a medical device.
-
Boston Scientific unlikely to meet guidance due to cyberattack
Despite making progress restoring global operations, the device maker said in a securities filing that it is unlikely to meet third-quarter and full-year sales and earnings forecasts.
-
Abbott wins FDA approval for dual-energy ablation catheter
CEO Robert Ford has said the atrial fibrillation treatment, along with the company's Volt PFA device, is expected to help Abbott regain market share in electrophysiology.
-
Retrieved from Elucid on September 08, 2026
Elucid raises $55M to commercialize cardiovascular imaging platform
Elucid, which gained a large medtech company as an investor, plans to grow industry partnerships as it looks to expand its AI-powered imaging platform.
-
Boston Scientific recall of spinal cord stimulator leads tied to more than 1,000 injuries
A problem with the leads could cause inadequate stimulation, Boston Scientific said. In the worst case, leads may need to be removed or replaced.
-
Boston Scientific begins to restore shipping after cyberattack
The company is working through a backlog after the cyberattack hampered manufacturing, order processing and shipping.
-
Vara receives CE mark for first autonomous breast cancer screening
The AI-enabled device can report screenings it determines are normal without radiologist review.
-
Abbott ablation device effective at 1 year in complex cases
Abbott said it will use the study results to secure FDA approval for the TactiFlex Duo catheter that offers both PFA and RF energy for tailoring treatment of atrial fibrillation.
-
NovoCure says cyberattack caused patient data exposure
The cancer treatment company said internal data from more than 1,400 patient records were exposed in a cyberattack detected in mid-August.
-
DaVita agrees to pay $15M to settle claims from data breach
The dialysis provider has opted to settle a proposed class action lawsuit stemming from a data breach last year that impacted 2.7 million people.
-
Medtronic invests $700M in Cornerstone Robotics
Medtronic will gain rights to distribute the Hong Kong-based company’s Sentire surgical robot in certain markets outside the U.S. alongside its own Hugo system.
-
Stryker to add rotator cuff repair tech with ZuriMED buy
Rotator cuff augmentation is one of the fastest-growing areas in sports medicine, according to Stryker.
-
Enovis inks eCential takeover to develop surgical ortho robots
The orthopedics specialist aims to launch a knee robot in late 2028, followed by a shoulder robot in 2029.
-
Medtronic kicks off its fiscal year on a high note
The medical device maker grew revenue by double digits in its fiscal first quarter, following fourth-quarter growth of nearly 10%.
-
MiniMed submits new patch pump for FDA clearance
The diabetes tech firm is preparing for the launch of new devices, including a tubeless insulin pump and a fully closed loop automated insulin delivery system.
-
Boston Scientific discontinues angiographic catheters
The company plans to stop selling its Imager II Angiographic Catheters after a manufacturing problem led the company to pull the devices from the market.
Updated Aug. 31, 2026 -
GE HealthCare secures CE mark for photon-counting CT device
GE HealthCare is challenging Siemens Healthineers in the market for a technology that is designed to provide clearer images than traditional CT systems.
-
Kardium receives $31M investment from Canada for manufacturing expansion
The company received FDA approval for its pulsed field ablation system last year and closed a $250 million funding round.
-
Boston Scientific says cyberattack has disrupted product manufacturing
The attack has affected the company’s ability to manufacture products and to process and ship customers’ orders, and there is still no timeline for restoration.
-
Abbott wins CE mark for new LAA closure device
Abbott is aiming to capture share from Boston Scientific in the market for devices that seal the heart’s left atrial appendage to reduce stroke risk.
-
Medtronic recalls pH monitoring capsule linked to 184 serious injuries
For the second time in two years, Medtronic has pulled capsules from the market over a fault that could obstruct patients’ airways.
-
J&J’s latest Impella recall tied to 3 deaths, 37 injuries
Hospitals can use automated controllers in inventory while waiting for service from J&J’s Abiomed business to ensure patients who need Impella heart pumps can still receive care.